查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1762332

外用药CDMO市场，规模，占有率，趋势，产业分析报告:各製剂，各类服务，各最终用途，各地区，2025年～2034年的市场预测

Topical Drugs CDMO Market Size, Share, Trends, & Industry Analysis Report By Formulation (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products), Service, End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 130 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，全球外用药物CDMO市场规模预计到2034年将达到1,254.2亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

外用药物CDMO市场是指为直接用于皮肤或黏膜的药品开发、製剂和生产提供全面服务的专业公司。这些服务涵盖外用药物的整个生命週期，从早期研发到大规模商业化生产。本质上，CDMO是製药和生物製药公司的关键合作伙伴，帮助他们有效率地将各种外用药物推向市场，并符合严格的监管标准。

湿疹、牛皮癣和痤疮等各种皮肤病在全球范围内的流行率不断上升，刺激了对创新外用药物的需求。这使得製药公司依赖在配製和生产复杂外用药物（包括黏膜药物）方面拥有专业知识的CDMO。此外，受成本效益和灵活生产能力需求的推动，製药业外包趋势日益增长，进一步刺激了对外用CDMO服务的需求。

外用药物CDMO市场报告重点

按剂型划分，半固体製剂在2024年占据最大占有率，这得益于其在皮肤科、疼痛管理和抗感染等各种治疗领域的广泛应用。

按服务划分，合约製造业在2024年占据了市场主导地位，因为製药公司越来越多地将外用药物的实际製造外包，以利用专业知识、降低营运成本和可扩展的製造能力。

按最终用途划分，製药公司在2024年占据了最大占有率，这得益于製药公司持续开发和商业化从非处方药到处方药的各种外用药物组合。

按地区划分，2024 年亚太地区占据外用药物 CDMO 市场的最大占有率。这主要得益于製造成本效益、不断扩大的医疗基础设施以及中国和印度等国家製药业的蓬勃发展，使其成为全球外用药物製造外包的理想地点。

市场主要参与者包括路博润公司（路博润生命科学）、Cambrex 公司、龙沙集团、康泰伦特公司、Recipharm AB、皮埃尔法伯公司、Piramal Pharma Solutions、PCI Pharma Services、MedPharm Ltd.、Tergus Pharma 和 Contract Pharmaceuticals Limited。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球外用药CDMO市场洞察

  • 市场概述
  • 外用药CDMO市场动态
    • 促进因素和机会
      • 皮肤病发生率上升
      • 医药外包的成长趋势
    • 限制与课题
      • 监管的复杂性和严格性
  • PESTEL分析
  • 外用药CDMO市场应用趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球外用药CDMO市场:各製剂

  • 主要调查结果
  • 简介
  • 半固态製剂
  • 液体製剂
  • 固态製剂
  • 经皮吸收型产品

第6章 全球外用药CDMO市场:各类服务

  • 主要调查结果
  • 简介
  • 契约开发
  • 契约製造

第7章 全球外用药CDMO市场:各最终用途

  • 主要调查结果
  • 简介
  • 製药公司
  • 生物医药品企业
  • 其他

第8章 全球外用药CDMO市场:各地区

  • 主要调查结果
  • 简介
    • 外用药CDMO市场分析:各地区，2020年～2034年
  • 北美
    • 北美:各製剂，2020～2034年
    • 北美:各类服务，2020～2034年
    • 北美:各最终用途，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各製剂，2020～2034年
    • 欧洲:各类服务，2020～2034年
    • 欧洲:各最终用途，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各製剂，2020～2034年
    • 亚太地区:各类服务，2020～2034年
    • 亚太地区:各最终用途，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各製剂，2020～2034年
    • 中东·非洲:各类服务，2020～2034年
    • 中东·非洲:各最终用途，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:各製剂，2020～2034年
    • 南美:各类服务，2020～2034年
    • 南美:各最终用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Cambrex Corporation
  • Catalent Inc.
  • Contract Pharmaceuticals Limited
  • MedPharm Ltd.
  • PCI Pharma Services
  • Pierre Fabre S.A.
  • Piramal Pharma Solutions
  • Recipharm AB
  • Tergus Pharma
  • The Lubrizol Corporation(Lubrizol Life Science)
Product Code: PM5815

The topical drugs cdmo market global market size is expected to reach USD 125.42 billion by 2034, according to a new study by Polaris Market Research. The report "Topical Drugs CDMO Market Size, Share, Trends, & Industry Analysis Report By Formulation (Semi-solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products), By Service, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The topical drugs CDMO market refers to specialized companies that provide comprehensive services for the development, formulation, and production of pharmaceutical products designed to be applied directly to the skin or mucous membranes. These services span the entire lifecycle of a topical drug, from initial research and development to the large-scale manufacturing of commercial products. Essentially, CDMOs act as crucial partners for pharmaceutical and biopharmaceutical companies, helping them bring a wide array of topical medications to market efficiently and in compliance with strict regulatory standards.

The increasing global prevalence of various skin conditions, such as eczema, psoriasis, and acne, fuels the demand for innovative topical treatments. This, in turn, leads pharmaceutical companies to rely on CDMOs for their specialized expertise in formulating and producing complex topical medications, including mucosal drugs. Additionally, the growing trend of outsourcing within the pharmaceutical industry, driven by cost-efficiency and the need for flexible manufacturing capabilities, further boosts the demand for topical drugs CDMO services.

Topical Drugs CDMO Market Report Highlights

By formulation, the semi-solid formulations segment held the largest share in 2024 due to their widespread use across various therapeutic areas such as dermatology, pain management, and anti-infectives.

Based on service, the contract manufacturing segment dominated the market in 2024, as pharmaceutical companies increasingly outsource the actual production of their topical drugs to leverage specialized expertise, reduce operational costs, and benefit from scalable manufacturing capabilities.

By end use, the pharmaceutical companies segment held the largest share in 2024 as they consistently develop and commercialize a broad portfolio of topical drugs, from over-the-counter to prescription medications.

By region, Asia Pacific held the largest share of the topical drugs CDMO market in 2024. This is primarily attributed to cost-effectiveness in manufacturing, expanding healthcare infrastructure, and growing pharmaceutical industries in countries such as China and India, making it an attractive hub for global outsourcing of topical drug production.

A few key players in the market include The Lubrizol Corporation (Lubrizol Life Science), Cambrex Corporation, Lonza Group AG, Catalent Inc., Recipharm AB, Pierre Fabre S.A., Piramal Pharma Solutions, PCI Pharma Services, MedPharm Ltd., Tergus Pharma, and Contract Pharmaceuticals Limited.

Polaris Market Research has segmented the topical drugs CDMO market report based on formulation, service, end use, and region:

By Formulation Outlook (Revenue - USD Billion, 2020-2034)

Semi-solid Formulations

Creams

Ointments

Gel

Others

Liquid Formulations

Solid Formulations

Transdermal Products

By Service Outlook (Revenue - USD Billion, 2020-2034)

Contract Development

Contract Manufacturing

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Pharmaceutical Companies

Biopharmaceutical Companies

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Topical Drugs CDMO Market Insights

  • 4.1. Topical Drugs CDMO Market - Market Snapshot
  • 4.2. Topical Drugs CDMO Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Skin Conditions
      • 4.2.1.2. Growing Trend of Pharmaceutical Outsourcing
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory Complexity and Stringency
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Topical Drugs CDMO Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Topical Drugs CDMO Market, by Formulation

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • 5.3. Semi-solid Formulations
    • 5.3.1. Global Topical Drugs CDMO Market, by Semi-solid Formulations, by Region, 2020-2034 (USD Billion)
  • 5.4. Liquid Formulations
    • 5.4.1. Global Topical Drugs CDMO Market, by Liquid Formulations, by Region, 2020-2034 (USD Billion)
  • 5.5. Solid Formulations
    • 5.5.1. Global Topical Drugs CDMO Market, by Solid Formulations, by Region, 2020-2034 (USD Billion)
  • 5.6. Transdermal Products
    • 5.6.1. Global Topical Drugs CDMO Market, by Transdermal Products, by Region, 2020-2034 (USD Billion)

6. Global Topical Drugs CDMO Market, by Service

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • 6.3. Contract Development
    • 6.3.1. Global Topical Drugs CDMO Market, by Contract Development, by Region, 2020-2034 (USD Billion)
  • 6.4. Contract Manufacturing
    • 6.4.1. Global Topical Drugs CDMO Market, by Contract Manufacturing, by Region, 2020-2034 (USD Billion)

7. Global Topical Drugs CDMO Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Pharmaceutical Companies
    • 7.3.1. Global Topical Drugs CDMO Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
  • 7.4. Biopharmaceutical Companies
    • 7.4.1. Global Topical Drugs CDMO Market, by Biopharmaceutical Companies, by Region, 2020-2034 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Topical Drugs CDMO Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Topical Drugs CDMO Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Topical Drugs CDMO Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Topical Drugs CDMO Market - North America
    • 8.3.1. North America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
    • 8.3.2. North America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
    • 8.3.3. North America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Topical Drugs CDMO Market - U.S.
      • 8.3.4.1. U.S.: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Topical Drugs CDMO Market - Canada
      • 8.3.5.1. Canada: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Topical Drugs CDMO Market - Europe
    • 8.4.1. Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Topical Drugs CDMO Market - UK
      • 8.4.4.1. UK: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Topical Drugs CDMO Market - France
      • 8.4.5.1. France: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Topical Drugs CDMO Market - Germany
      • 8.4.6.1. Germany: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Topical Drugs CDMO Market - Italy
      • 8.4.7.1. Italy: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Topical Drugs CDMO Market - Spain
      • 8.4.8.1. Spain: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Topical Drugs CDMO Market - Netherlands
      • 8.4.9.1. Netherlands: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Topical Drugs CDMO Market - Russia
      • 8.4.10.1. Russia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Topical Drugs CDMO Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Topical Drugs CDMO Market - Asia Pacific
    • 8.5.1. Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Topical Drugs CDMO Market - China
      • 8.5.4.1. China: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Topical Drugs CDMO Market - India
      • 8.5.5.1. India: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Topical Drugs CDMO Market - Malaysia
      • 8.5.6.1. Malaysia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Topical Drugs CDMO Market - Japan
      • 8.5.7.1. Japan: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Topical Drugs CDMO Market - Indonesia
      • 8.5.8.1. Indonesia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Topical Drugs CDMO Market - South Korea
      • 8.5.9.1. South Korea: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Topical Drugs CDMO Market - Australia
      • 8.5.10.1. Australia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Topical Drugs CDMO Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Topical Drugs CDMO Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Topical Drugs CDMO Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Topical Drugs CDMO Market - UAE
      • 8.6.5.1. UAE: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Topical Drugs CDMO Market - Israel
      • 8.6.6.1. Israel: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Topical Drugs CDMO Market - South Africa
      • 8.6.7.1. South Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Topical Drugs CDMO Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Topical Drugs CDMO Market - Latin America
    • 8.7.1. Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Topical Drugs CDMO Market - Mexico
      • 8.7.4.1. Mexico: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Topical Drugs CDMO Market - Brazil
      • 8.7.5.1. Brazil: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Topical Drugs CDMO Market - Argentina
      • 8.7.6.1. Argentina: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Topical Drugs CDMO Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Cambrex Corporation
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Catalent Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Contract Pharmaceuticals Limited
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. MedPharm Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. PCI Pharma Services
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Pierre Fabre S.A.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Piramal Pharma Solutions
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Recipharm AB
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Tergus Pharma
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. The Lubrizol Corporation (Lubrizol Life Science)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 2 Global Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 3 Global Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 North America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 5 North America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 6 North America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 U.S.: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 8 U.S.: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 9 U.S.: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 10 Canada: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 11 Canada: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 12 Canada: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 14 Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 15 Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 UK: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 17 UK: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 18 UK: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 France: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 20 France: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 21 France: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 22 Germany: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 23 Germany: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 24 Germany: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Italy: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 26 Italy: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 27 Italy: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 Spain: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 29 Spain: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 30 Spain: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 34 Russia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 35 Russia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 36 Russia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 China: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 44 China: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 45 China: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 India: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 47 India: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 48 India: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Japan: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 53 Japan: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 54 Japan: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 58 South Korea: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 59 South Korea: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 60 South Korea: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Australia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 62 Australia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 63 Australia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 UAE: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 74 UAE: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 75 UAE: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Israel: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 77 Israel: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 78 Israel: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 79 South Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 80 South Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 81 South Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 86 Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 87 Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Mexico: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 89 Mexico: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 90 Mexico: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Brazil: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 92 Brazil: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 93 Brazil: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 94 Argentina: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 95 Argentina: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 96 Argentina: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Topical Drugs CDMO Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Formulation
  • Figure 7. Global Topical Drugs CDMO Market, by Formulation, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Service
  • Figure 9. Global Topical Drugs CDMO Market, by Service, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Topical Drugs CDMO Market, by End Use, 2024 & 2034 (USD Billion)